Safety, adherence and discontinuation in varenicline solution nasal spray clinical trials for dry eye disease

Conclusion: In clinical trials, VNS demonstrated improvements in dry eye disease signs and symptoms, was well-tolerated, and had an overall completion rate >93%. Conventional dry eye treatments (e.g., cyclosporine and lifitegrast) noted considerably higher discontinuation rates in their clinical trials.PMID:37096956 | DOI:10.57264/cer-2022-0215
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Authors: Source Type: research